Ontvang nu dagelijks onze kooptips!

word abonnee
IEX 25 jaar
Uitgebreid zoeken

Beurscodes, betekenis en hulp bij zoeken

Europa

AEX
Euronext Amsterdam
BRU
Euronext Brussels
PSE
Euronext Paris
LIS
Euronext Lissabon
CHX
CBOE Europe, grote(re) EU aandelen
NAV
Investment Funds (NAV)

Noord-Amerika

NYS
New York Stock Exchange
OTC
CBOE BZX Exchange (US)
TSE
Toronto Stock Exchange

Kunt u een instrument niet vinden?

Zoek dan via de zogenaamde ISIN code. Elk instrument, aandeel etc. heeft een unieke code.

Kies vervolgens - wanneer er meerdere resultaten zijn - de notering op de beurs van uw keuze.

Waar vind ik die ISIN code?

Google de naam van het instrument, aandeel etc. met de toevoeging 'ISIN'.

Als zoeken op ISIN code geen resultaten oplevert hebben wij het instrument of aandeel niet in onze koersendatabase.

desktop iconMarkt Monitor
Markt vandaag Koersen Forum Premium IEX Expert
Home  /   Forum   /   Koffiekamer   /   welke pennystock kan je het beste kopen?

Koffiekamer« Terug naar discussie overzicht

welke pennystock kan je het beste kopen?

Volgen
1.287 Posts
Pagina: «« 1 ... 51 52 53 54 55 ... 65 »» | Laatste | Omlaag ↓
  7. Wereldhave 11 april 2024 14:06
    MKB Nedsense heeft een belang in Tib-Tec AG.

    TIB-TEC AG recently organized an event for its investors on November 29th, 2023 in Amsterdam, hosted by its CEO, Kai Niedermeyer, alongside the Board of Directors. The event served as a platform to provide comprehensive updates on recent achievements, shedding light on significant milestones and outlining the company’s strategic trajectory moving forward.

    Here are the key highlights from the event:

    Technology Development Milestones: The event provided an insight on the recent achievements in technology development. TIB-TEC proudly announced the successful results stemming from its latest round of tests, underscoring the company’s commitment to innovation and advancement in its field.
    Legal and Patent Applications: In addition to technological progress, TIB-TEC also highlighted significant accomplishments in the legal realm, particularly emphasizing progress in patent applications. This underscores the company’s dedication to protecting its intellectual property and fostering a robust foundation for future growth.
    Industry Focus: An integral component of the event was the discussion surrounding the industries TIB-TEC is targeting. The company provided insights into the specific sectors it aims to penetrate, highlighting strategic opportunities for growth and innovation.
    Outlook on R&D and Business Development: Attendees were presented a comprehensive outlook on the company’s future endeavors, with a particular focus on Research and Development (R&D) initiatives and Business Development strategies. TIB-TEC delineated the steps ahead, explaining its vision for continued expansion and success.
    With an impressive turnout of over 80 attendees, the event was a great success. It fostered fruitful interactions and immediate follow-up discussions with investors, who demonstrated their commitment to supporting TIB-TEC’s future growth plans. The enthusiastic engagement of investors underscores the confidence in the company’s vision and potential.

    In conclusion, the TIB-TEC Investor Event was an important moment in the company’s journey, showcasing notable achievements, outlining strategic priorities, and fostering valuable investor relationships. As TIB-TEC continues to chart a course towards innovation and growth, the event stands as a testament to the company’s firm commitment to excellence and forward-thinking leadership.

    Zie:
    tib-tec.com
  10. forum rang 10 DeZwarteRidder 12 april 2024 10:48
    quote:

    StudentBelegger schreef op 12 april 2024 10:46:

    Biosenic op dit moment al 24hr suspended by market operators met een nieuwsbericht op EuroNext over een 'global restructuring plan covering the years 2024-2030'. Voorspelling wat hier de uitkomst van gaat zijn?
    Veel nieuwe aandelen en verwatering.
  11. forum rang 4 Diede 12 april 2024 12:31
    quote:

    StudentBelegger schreef op 12 april 2024 10:46:

    Biosenic op dit moment al 24hr suspended by market operators met een nieuwsbericht op EuroNext over een 'global restructuring plan covering the years 2024-2030'. Voorspelling wat hier de uitkomst van gaat zijn?
    Je kan je geld terugvorderen bij Brugge.
  14. StudentBelegger 15 april 2024 09:42
    quote:

    Diede schreef op 12 april 2024 12:31:

    [...]
    Je kan je geld terugvorderen bij Brugge.
    Vaker stuivers gegraaid bij dit aandeel met kleine bedragen 6-10% pakken op een dag en een paar keer verlies genomen als het orderboek geen stijging meer voorziet.
    Koers houd zich nog sterk, gezien het orderboek zal de koers nog wel even tussen 0,2 en 0,26 kunnen bungelen. Genoeg ruimte voor daghandel!
  17. forum rang 10 DeZwarteRidder 15 april 2024 13:41
    BioSenic S.A. • Rue Granbonpré 11 - Building H (box 24) • 1435 Mont-St-Guibert • Belgium (Europe) • Phone: +32 (0)493 09 73 66
    www.biosenic.com
    PRESS RELEASE - PRIVILEGED INFORMATION 11/04/2024
    1
    BioSenic and its restructuring practitioner (Me Yves Brulard) submit a
    global restructuring plan covering the years 2024-2030 to the Enterprise
    Court of Nivelles
    A final circular of the creditors on the basis of XX 83/23 of the Economic Law Code (ELC) will take place before the
    Court grants authorisation, in accordance with article XX 83/26 of the ELC, to submit the plan to the vote of each
    class of creditors and to homologation. The creditors will be aware of the plan, which by law contains information
    that could be privileged.
    Mont-Saint-Guibert, Belgium, 11 April 2024, 14:00 CET – BioSenic (Euronext Brussels and Paris: BIOS), the
    clinical-stage company specializing in serious autoimmune and inflammatory diseases and cell therapy announces that it
    has finalised a draft plan with the request referred to in Article XX 83/26 ELC with the Enterprise Court of Nivelles. Creditors
    will be notified to register their claims in RegSol. They will be able to consult this plan in order to then vote on the proposals
    made.
    The proposed plan provides for differentiated treatment of creditors by class:
    • The plan does not affect the recent financing provided through the convertible bond facilities.
    • Some obligators have been offered to replace their outstanding loans granted to BioSenic for a total principal
    amount of EUR 7.5 million with new convertible bonds to be issued by BioSenic. The convertible bonds would be
    unsecured and would have a maturity date of 31 December 2030, which could be further extended by BioSenic
    for up to 24 months depending on its cash balance. An interest rate of 5% per year, payable annually, with an
    additional non-compounding interest of 3% per year that would be added to the principal amount upon conversion
    or repayment of a convertible bond. Under this proposal, which has already been agreed in principle, 200,000
    outstanding warrants would be cancelled. The plan, if approved, would remove the conditions precedent
    previously agreed.
    • The plan provides that an outstanding EUR 8 million principal loan would be replaced by new convertible bonds
    to be issued by BioSenic. The convertible bonds would be unsecured and would have a maturity date of 31
    December 2030, which could be further extended by BioSenic for up to 24 months depending on its cash balance.
    An interest rate of 5% per year, payable annually, with an additional non-compounding interest of 3% per year
    that will be added to the principal amount upon conversion or repayment of a convertible bond. If the plan is
    approved, 800,000 outstanding warrants would also be cancelled.
    • With regard to the ordinary creditors, the plan provides for a payment by BioSenic of 5% of the claim on the last
    day of the 5th year of the plan.
    • With respect to the lessor, the plan provides for the extraordinary part 100% immediately and the balance in
    ordinary.
    • Regarding the strategic creditors, the plan provides for 90% over 5 years depending on cash inflows and no later
    than the last day of the 5th year of the plan.
    • For the accessories employee, the plan provides for 99% immediately.
    • The plan provides, for the very useful creditors, for 50% within 2 years.
    • Regarding the InterCos debts, the plan provides for 5% immediately.
    • Finally, with regard to the shareholders, the plan provides for the allocation of subscription rights, the terms of
    which will be determined at a later date by BioSenic.
    The plan includes a participation clause at the reorganisation value, due on the last day of the 5th year following the
    homologation of the plan on the basis of the average share price over the preceding 90 days. This participation amount –
    to be deducted from the company's own financing capacity for projects in the 5th year, with trials to be started or even
    maintained on new indications – will be due on the last day of the 5th year following the homologation of the plan, and will
    be assessed on the basis of the average share price over the preceding 90 days: the average share price will have to reach
    the level observed for the shares of BioSenic in 2017 while a Phase III was ongoing (JTA004). At that time, the share price
    stood at EUR 10. If this level is reached, the participation of every creditor will be increased by 10% of the debt written off.
1.287 Posts
Pagina: «« 1 ... 51 52 53 54 55 ... 65 »» | Laatste |Omhoog ↑

Meedoen aan de discussie?

Word nu gratis lid of log in met je emailadres en wachtwoord.

Direct naar Forum

Markt Vandaag

Stijgers

instrument koers absoluut verschil relatief verschil
IMCD 152,900 +8,60 +5,96%
Aperam 27,360 +1,42 +5,47%
HEIJMANS KON 26,200 +1,10 +4,38%
UMG 23,710 +0,46 +1,98%
SBM Offshore 17,810 +0,28 +1,60%
RELX 44,640 +0,66 +1,50%
NSI 19,740 +0,26 +1,33%
Eurocommercial Properties 23,450 +0,30 +1,30%
CTP 14,700 +0,18 +1,24%
Ahold Delhaize 32,390 +0,34 +1,06%
WDP 21,200 +0,22 +1,05%
JUST EAT TAKEAWAY 11,295 +0,12 +1,03%
Vopak 43,080 +0,42 +0,98%
TKH 36,500 +0,32 +0,88%
Wolters Kluwer 161,850 +1,40 +0,87%
AMG Critical Materials N.V. 15,210 +0,13 +0,86%
Wereldhave 14,180 +0,12 +0,85%
Fagron 18,960 +0,16 +0,85%
KPN 3,618 +0,03 +0,81%
BESI 109,500 +0,70 +0,64%
JDE PEET'S 18,850 +0,07 +0,37%
Nedap N.V. 54,800 +0,20 +0,37%
Basic-Fit 22,820 +0,08 +0,35%
ACOMO 17,360 +0,04 +0,23%
BAM 4,160 +0,01 +0,19%
DSM FIRMENICH AG 104,800 +0,05 +0,05%
ING 14,990 +0,01 +0,04%
AZERION 1,296 0,00 0,00%
B&S Group SA 4,500 0,00 0,00%
Kendrion 11,000 0,00 0,00%
Vastned 24,500 0,00 0,00%

Dalers

instrument koers absoluut verschil relatief verschil
Alfen N.V. 11,700 -1,85 -13,65%
EBUSCO HOLDING 3,390 -0,46 -11,96%
ADYEN NV 1.272,600 -63,20 -4,73%
RANDSTAD NV 42,000 -1,52 -3,49%
INPOST 17,480 -0,47 -2,62%
Pharming 0,738 -0,02 -2,57%
PROSUS 38,440 -1,02 -2,57%
Fugro 16,760 -0,44 -2,56%
Philips Koninklijke 24,870 -0,63 -2,47%
Avantium 2,200 -0,05 -2,44%
Accsys 0,590 -0,01 -2,32%
THEON INTERNAT 8,980 -0,21 -2,29%
CM.COM 6,250 -0,13 -2,04%
FASTNED 21,800 -0,45 -2,02%
Air France-KLM 7,780 -0,16 -2,02%
Brunel 8,780 -0,18 -2,01%
ArcelorMittal 24,140 -0,49 -1,99%
Sif Holding 13,140 -0,24 -1,79%
Galapagos 25,120 -0,42 -1,64%
SIGNIFY NV 21,680 -0,36 -1,63%
Aegon 6,144 -0,09 -1,48%
NX FILTRATION 4,540 -0,07 -1,41%
ALLFUNDS GROUP 5,500 -0,07 -1,26%
PostNL 1,001 -0,01 -1,18%
SHELL PLC 31,250 -0,36 -1,15%
Akzo Nobel 58,820 -0,58 -0,98%
Corbion 22,360 -0,22 -0,97%
EXOR NV 94,650 -0,90 -0,94%
ASR Nederland 44,870 -0,32 -0,71%
ABN AMRO BANK N.V. 15,220 -0,10 -0,69%
TomTom 5,245 -0,04 -0,66%
ASMI 508,800 -2,80 -0,55%
ASML 621,500 -3,20 -0,51%
AEX 874,18 -4,36 -0,50%
Heineken 72,580 -0,36 -0,49%
Flow Traders 21,500 -0,10 -0,46%
RENEWI 7,360 -0,03 -0,41%
OCI 10,700 -0,04 -0,33%
UNILEVER PLC 54,560 -0,14 -0,26%
NN Group 45,130 -0,10 -0,22%
Sligro 11,160 -0,02 -0,18%
AMX 867,36 -1,40 -0,16%
ForFarmers 3,415 0,00 -0,15%
Van Lanschot Kempen NV 41,800 -0,05 -0,12%
ASCX 1.198,78 -1,05 -0,09%
Arcadis 65,100 -0,05 -0,08%
AALBERTS NV 35,120 -0,02 -0,06%
vlag naam koers verschil relatief verschil
AEX 874,18 -4,36 -0,50%
AEX GR 3.422,93 -17,05 -0,50%
Germany40^ 19.238,10 +22,62 +0,12%
FTSE 100 8.072,39 -68,35 -0,84%
EURO50 4.814,83 0,00 0,00%
US30^ 44.011,10 0,00 0,00%
Nasd100^ 21.123,70 0,00 0,00%
US500^ 6.000,22 0,00 0,00%
Japan225^ 39.109,80 0,00 0,00%
VD-NEW 15,36 -0,09 -0,58%
#/^ Index indications calculated real time, zie disclaimer